Free Trial

Quest Diagnostics (DGX) Earnings Date, Estimates & Call Transcripts

Quest Diagnostics logo
$172.44 +0.30 (+0.17%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$172.24 -0.19 (-0.11%)
As of 02/21/2025 07:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quest Diagnostics Latest Earnings Summary

Upcoming Q1
Earnings Date
Apr. 22Before Market OpensEstimated
Actual EPS
(Jan. 30)
$2.23 Beat By $0.04
Consensus EPS
(Jan. 30)
$2.19

Quest Diagnostics released Q4 2024 earnings on January 30, 2025, reporting an EPS of $2.23, which topped the consensus estimate of $2.19 by $0.04. With a trailing EPS of $7.69 and a P/E Ratio of 22.42, Quest Diagnostics' earnings are expected to grow 8.14% next year, from $9.70 to $10.49 per share.

DGX Upcoming Earnings

Quest Diagnostics' next earnings date is estimated for Tuesday, April 22, 2025, based off prior year's reporting schedules.

Get Quest Diagnostics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Quest Diagnostics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

DGX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DGX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Quest Diagnostics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20253$2.17$2.21$2.19 
Q2 20253$2.43$2.61$2.52 
Q3 20253$2.48$2.50$2.49 
Q4 20253$2.44$2.62$2.51 
FY 202512$9.52$9.94$9.71 
Q1 20261$2.61$2.61$2.61 
Q2 20262$2.60$2.83$2.72 
Q3 20261$2.61$2.61$2.61 
Q4 20262$2.59$2.69$2.64 
FY 20266$10.41$10.74 $10.58

Quest Diagnostics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/22/2025
(Estimated)
-------
1/30/2025Q4 2024$2.19$2.23+$0.04$1.95$2.58B-
10/22/2024Q3 2024$2.26$2.30+$0.04$2.61$2.43B$2.49B
7/23/2024Q2 2024$2.31$2.35+$0.04$2.67$2.39B$2.40B
4/23/2024Q1 2024$1.86$2.04+$0.18$2.36$2.29B$2.37B
2/1/2024Q4 2023$2.11$2.15+$0.04$2.60$2.25B$2.29B
10/24/2023Q3 2023$2.19$2.22+$0.03$2.48$2.27B$2.30B
7/26/2023Q2 2023$2.23$2.30+$0.07$2.55$2.25B$2.34B
4/27/2023Q1 2023$1.97$2.04+$0.07$2.30$2.20B$2.33B

Quest Diagnostics Earnings - Frequently Asked Questions

Quest Diagnostics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 22nd, 2025 based off last year's report dates. Learn more on DGX's earnings history.

Quest Diagnostics updated its FY 2025 earnings guidance on Thursday, January, 30th. The company provided earnings per share guidance of 9.550-9.800 for the period, compared to the consensus estimate of 9.720. The company issued revenue guidance of $10.7 billion-$10.9 billion, compared to the consensus revenue estimate of $10.7 billion.

In the previous quarter, Quest Diagnostics (NYSE:DGX) reported $2.23 earnings per share (EPS) to beat the analysts' consensus estimate of $2.19 by $0.04. Learn more on analysts' earnings estimate vs. DGX's actual earnings.

The conference call for Quest Diagnostics's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Quest Diagnostics's latest earnings report can be read online.
Read Transcript

Quest Diagnostics (NYSE:DGX) has a recorded annual revenue of $9.87 billion.

Quest Diagnostics (NYSE:DGX) has a recorded net income of $871 million. DGX has generated $7.69 earnings per share over the last four quarters.

Quest Diagnostics (NYSE:DGX) has a trailing price-to-earnings ratio of 22.42 and a forward price-to-earnings ratio of 17.78. The price/earnings-to-growth ratio is 2.15.

Quest Diagnostics's earnings are expected to grow from $9.70 per share to $10.49 per share in the next year, which is a 8.14% increase.

More Earnings Resources from MarketBeat



This page (NYSE:DGX) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners